Evidence Base for Treatment of Infectious Bovine Keratoconjunctivitis.

Animals Anti-Bacterial Agents / therapeutic use Cattle Cattle Diseases / drug therapy Keratoconjunctivitis, Infectious / drug therapy
Antibiotics Infectious Bovine Keratoconjunctivitis Randomized control trials study design Treatments

Journal

The Veterinary clinics of North America. Food animal practice
ISSN: 1558-4240
Titre abrégé: Vet Clin North Am Food Anim Pract
Pays: United States
ID NLM: 8511905

Informations de publication

Date de publication:
Jul 2021
Historique:
entrez: 29 5 2021
pubmed: 30 5 2021
medline: 22 6 2021
Statut: ppublish

Résumé

In this article, the evidence base for treating infectious bovine keratoconjunctivitis (IBK) is discussed. First, we summarize the available evidence for antibiotic treatments registered in North America. We then discuss the evidence base for nonantibiotic alternatives. We do not discuss antibiotic treatments that do not use registered protocols; such information is available in another review. Finally, we discuss how the research community could generate more evidence for effective treatments and the comparative efficacy information to help veterinarians and producers decide between treatment options.

Identifiants

DOI: 10.1016/j.cvfa.2021.03.008 PMID: 34049663
pubmed: 34049663
pii: S0749-0720(21)00027-X
doi: 10.1016/j.cvfa.2021.03.008
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-339

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure Both the authors have nothing to disclose.

Auteurs

Annette M O'Connor (AM)

Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, 784 Wilson Road, Room G-100, East Lansing, MI 48824, USA. Electronic address: oconn445@msu.edu.

Mac Kneipp (M)

Sydney School of Veterinary Science, The University of Sydney, Camden, NSW, Australia.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Evidence Base for Treatment of Infectious...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Evidence Base for Treatment of Infectious...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Artiodactyla › Ruminants › Bovins › Evidence Base for Treatment of Infectious...
questionsmedicales.fr › Maladies de l'animal › Maladies des bovins › Evidence Base for Treatment of Infectious...
questionsmedicales.fr › Maladies de l'animal › Kératoconjonctivite infectieuse › Evidence Base for Treatment of Infectious...